Cellebrite DI Ltd. share price logo

Cellebrite DI Ltd.

NASDAQ: CLBT

Mid Cap

$13.76

+1.13

(+8.95%)

as on

Cellebrite DI Ltd. Stock Performance

as on June 27, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $12.57
    $13.74
    downward going graph

    8.65%

    Downside

    -0.15%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $11.02
    $19.98
    downward going graph

    19.91%

    Downside

    45.20%

    Upside

    downward going graph

Cellebrite DI Ltd. share price movements today

Previous Close
$12.63
Open
$12.57
Volume
2.5M
Day's Low - High
$12.57 - $13.74
52 Week Low - High
$11.02 - $19.98

Cellebrite DI Ltd. Historical Returns

1 Month Return
-2.02 %
3 Month Return
-8.41 %
1 Year Return
-22.56 %
3 Year Return
+ 100.48 %
5 Year Return
0 %

Cellebrite DI Ltd. Stock Fundamentals & Key Indicators

Check Cellebrite DI Ltd. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.2B

EPS (TTM)

0.5546

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.43%

PE Ratio (TTM)

45.45

Industry PE ratio

13.312368421052632

PEG Ratio

0

EBITDA

79.6M

Revenue (TTM)

496.4M

Profit Margin

14.48%

Return On Equity TTM

16.44%

Cellebrite DI Ltd. Stock Valuation

Track how Cellebrite DI Ltd. P/E has moved over time to understand its valuation trends.

Cellebrite DI Ltd. in the last 5 years

  • Overview

  • Trends

Lowest (16.54x)

December 31, 2022

Industry (13.31x)

June 26, 2026

Today (45.45x)

June 26, 2026

Highest (70.28x)

September 30, 2021

LowHigh

Today’s Price to Earnings Ratio: 45.45x

Cellebrite DI Ltd. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cellebrite DI Ltd. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$3.2BNA45.4514.48%NA
HOLD$272.1B300.56%127.5343.67%NA
BUY$171.3B167.99%NA-0.60%NA
BUY$232.5B368.23%245.917.95%NA
BUY$453.8B94.32%27.0225.37%1.21%

Stock Returns calculator for Cellebrite DI Ltd. Stock including INR - Dollar returns

The Cellebrite DI Ltd. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Cellebrite DI Ltd. investment value today

Current value as on today

₹92,831

Returns

-₹7,169

(-7.17%)

Returns from Cellebrite DI Ltd. Stock

-₹15,635 (-15.63%)

Dollar Impact

₹8,466 (+8.47%)

Analyst Recommendation on Cellebrite DI Ltd. Stock

Based on 14 analysts

BUY

92.86%

Buy

7.14%

Hold

0.00%

Sell

Based on 14 analysts, 92.86% of analysts recommend a 'BUY' rating for Cellebrite DI Ltd.. Average target price of $21

Cellebrite DI Ltd. Share Price Target

Get share price movements and forecasts by analysts on Cellebrite DI Ltd..

What analysts predicted

34.48%UPSIDE

Target Price

$21

Current Price

$13.76

Analyzed by

14 Analysts

Target

$21.00

Cellebrite DI Ltd. target price $21, a slight upside of 34.48% compared to current price of $13.76. According to 14 analysts rating.

Indian Investors' Interest in Cellebrite DI Ltd. Stock

Search interest for Cellebrite DI Ltd. Stock has decreased by -7% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-7% versus previous 30 day period

Cellebrite DI Ltd. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
93
89
95
106
109
107
113
126
128
128
Gross Profit
78
76
79
91
91
90
95
105
109
105
Operating Income
14
9
12
19
15
12
14
18
20
9
EBITDA
-91
11
15
22
-314
21
30
26
49
20
Interest Expense
27
78
34
223
1
-
-
-
-
-
Depreciation
2
2
2
2
2
2
2
2
3
7
Income Before Tax
-12
-69
-22
-204
19
19
20
24
26
13
Income Tax Expense
2
2
1
2
0
1
1
4
5
2
Net Income
-14
-71
-23
-207
19
17
19
20
21
10
Net Profit Margin
-15.75%
-79.67%
-24.88%
-193.80%
17.67%
16.18%
17.19%
16.02%
16.50%
8.53%

Cellebrite DI Ltd. Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
171
194
246
270
325
401
475
Gross Profit
136
157
203
219
271
338
400
Operating Income
-1
9
13
1
33
56
66
EBITDA
5
17
89
130
-65
-265
103
Interest Expense
0
1
0
0
0
349
0
Depreciation
4
5
7
9
9
10
11
Income Before Tax
1
11
82
120
-75
-275
90
Income Tax Expense
3
5
10
0
5
7
12
Net Income
-1
5
71
120
-81
-283
78
Net Profit Margin
-1.09%
2.97%
28.99%
44.63%
-24.95%
-70.54%
16.47%

Cellebrite DI Ltd. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-71
-23
-207
19
17
19
20
21
10
Operating Cash Flow
10
14
41
65
20
32
33
82
19
Investing Cash Flow
-81
-33
-18
-15
-126
40
63
-246
-13
Financing Cash Flow
5
3
5
6
3
13
5
6
3
Change in Cash
-67
-15
29
55
-101
88
102
-156
9

Cellebrite DI Ltd. Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
5
71
120
-81
-283
78
Operating Cash Flow
66
36
20
102
132
168
Investing Cash Flow
-6
45
-91
-22
-149
-268
Financing Cash Flow
-8
-68
13
21
20
29
Change in Cash
52
12
-58
101
2
-67

Global Institutional Holdings in Cellebrite DI Ltd.

Funds
Holdings
Ashford Capital Management Inc
0.71%
Phoenix Financial Ltd
1.68%
Nine Ten Capital Management LLC
1.38%
Handelsbanken Fonder AB
1%
Cooper Creek Partners Management LLC
0.96%

Cellebrite DI Ltd. News & Key Events

  • img

    Today's Timeline - 13 November

    Thu, 05:52 PM

    -

    Bank of America reiterates Buy rating on Cellebrite, highlighting recovery in Federal demand and growth potential.

    Thu, 08:52 PM

    -

    William Blair maintains Buy rating on CLBT, citing strong financial performance and promising growth prospects.

    Thu, 10:48 PM

    -

    Cellebrite stock climbs 23% after earnings beat expectations, with revenue and adjusted EBITDA also exceeding forecasts.

  • img

    Today's Timeline - 13 November

    Thu, 11:51 PM

    -

    Cellebrite reports strong Q3 results, raising full-year sales and ARR targets, boosting investor confidence.

Insights on Cellebrite DI Ltd.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, CLBT stock has moved up by 7.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Palantir Technologies Inc. Class A Common Stock has given 140.1% return, outperforming this stock by 43.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Palo Alto Networks, Inc. Common Stock has given 51.7% return, outperforming this stock by 64.8%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 21.26M → 10.93M (in $), with an average decrease of 48.6% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 128.82M → 128.30M (in $), with an average decrease of 0.4% per quarter

About Cellebrite DI Ltd.

Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company provides a platform of software solutions used to access, collect, review, extract, decode, decrypt, analyze, share and manage digital evidence across the investigative lifecycle for a range of investigations, such as child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime, human trafficking, corporate security, and intellectual property theft, as well as financial crimes, including those involving cryptocurrency. It also offers Inseyets, digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations; Guardian Forensics, an evidence management solution which enables customers to manage their digital forensics workflows, and to store, share and review digital evidence; Guardian Collaborate, a digital evidence sharing tool; and Guardian Investigate, a case management and AI-powered analytics solution. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence and enables actionable insights into a range of crime types; Corellium Falcon for conducting mobile vulnerability research, exploit introspection, and malware analysis; and Corellium Viper for mobile application penetration testing capabilities. Further, the company offers professional services, such as training and certification services, and advanced services. It serves federal, state, and local agencies, as well as corporations and service providers. The company is headquartered in Petah Tikva, Israel.
OrganisationCellebrite DI Ltd.
Headquarters94 Shlomo Shmelzer Road, Petah Tikva, Israel, 4970602
IndustrySoftware - Infrastructure
CEOMr. Thomas E. Hogan
E-voting on sharesClick here to vote

Key Management of Cellebrite DI Ltd.

Name

Title

Mr. Thomas E. Hogan

CEO & Director

Mr. Marcus Jewell

Global Chief Revenue Officer

Mr. Christopher Wade

Chief Technology Officer

Ms. Sigalit Shavit

Chief Information Officer

Andrew Kramer

Vice President of Investor Relations

Mr. David Nicholas Gee

Chief Marketing Officer

Mr. Shiven Ramji

President of Products & Technology

Mr. David Barter

Chief Financial Officer

Ms. Holly B. Windham Esq., J.D.

General Counsel & Chief Compliance Officer

Ms. Zohar Tadmor-Eilat

Chief People Officer

FAQs

What is Cellebrite DI Ltd. share price today?

Cellebrite DI Ltd. share price today is $13.76 as on at the close of the market. Cellebrite DI Ltd. share today touched a day high of $13.74 and a low of $12.57.

What is the 52 week high and 52 week low for Cellebrite DI Ltd. share?

Cellebrite DI Ltd. share touched a 52 week high of $19.98 on and a 52 week low of $11.02 on . Cellebrite DI Ltd. stock price today i.e. is closed at $13.76,which is 31.13% down from its 52 week high and 24.86% up from its 52 week low.

What is Cellebrite DI Ltd.'s market capitalisation today?

Cellebrite DI Ltd. market capitalisation is $0.00T as on .

How to invest in Cellebrite DI Ltd. Stock (CLBT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Cellebrite DI Ltd. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cellebrite DI Ltd. Shares that will get you 0.1090 shares as per Cellebrite DI Ltd. share price of $13.76 per share as on June 27, 2026 at 8:46 am IST.

What is the minimum amount required to buy Cellebrite DI Ltd. Stock (CLBT) from India?

Indian investors can start investing in Cellebrite DI Ltd. (CLBT) shares with as little as ₹94.3 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹943.00 in Cellebrite DI Ltd. stock (as per the Rupee-Dollar exchange rate as on ). Based on Cellebrite DI Ltd. share’s latest price of $13.76 as on June 27, 2026 at 8:46 am IST, you will get 0.7267 shares of Cellebrite DI Ltd.. Learn more about fractional shares .